Buprenorphine is:
**Core Concept**
Buprenorphine is a partial opioid agonist used for managing opioid use disorder, pain management, and in some cases, for managing withdrawal symptoms. It works by activating the mu-opioid receptor, but with a lower efficacy compared to full opioid agonists like morphine.
**Why the Correct Answer is Right**
Buprenorphine's partial agonist activity at the mu-opioid receptor is responsible for its therapeutic effects. This means it can produce analgesia and reduce withdrawal symptoms without causing significant respiratory depression or euphoria, which are common side effects of full opioid agonists. Buprenorphine's ceiling effect on respiratory depression is a key benefit in its use for opioid use disorder treatment.
**Why Each Wrong Option is Incorrect**
**Option A:** Buprenorphine is a full opioid agonist. This is incorrect because buprenorphine's partial agonist activity limits its potential for respiratory depression and euphoria.
**Option B:** Buprenorphine is a pure antagonist of the mu-opioid receptor. This is incorrect because buprenorphine has agonist activity at the mu-opioid receptor, albeit with lower efficacy.
**Option C:** Buprenorphine is a direct NMDA receptor antagonist. This is incorrect because buprenorphine's primary mechanism of action is through agonism of the mu-opioid receptor, not direct antagonism of NMDA receptors.
**Clinical Pearl / High-Yield Fact**
Buprenorphine's partial agonist activity and unique pharmacokinetic profile make it a valuable treatment option for opioid use disorder. Its use is often associated with induction of opioid substitution therapy, which can lead to improved treatment outcomes and reduced risk of overdose.
**Correct Answer:** C.